Willis Towers Watson PLC is an insurance brokers business based in the US. Willis Towers Watson shares (WTW) are listed on the NASDAQ and all prices are listed in US Dollars. Willis Towers Watson employs 44,000 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $199.87 |
|---|---|
| 52-week range | $187.89 - $248.02 |
| 50-day moving average | $211.68 |
| 200-day moving average | $227.76 |
| Wall St. target price | $247.14 |
| PE ratio | 7.1434 |
| Dividend yield | $3.24 (1.67%) |
| Earnings per share (TTM) | $28.69 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $199.87 from 2022-06-29
| 1 week (2022-06-23) | 1.01% |
|---|---|
| 1 month (2022-05-27) | -6.97% |
| 3 months (2022-03-30) | -16.72% |
| 6 months (2021-12-26) | N/A |
| 1 year (2021-06-30) | 452.59% |
|---|---|
| 2 years (2020-06-30) | 685.04% |
| 3 years (2019-06-28) | 948.36% |
| 5 years (2017-06-30) | 37.41% |
Valuing Willis Towers Watson stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Willis Towers Watson's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Willis Towers Watson's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, Willis Towers Watson shares trade at around 7x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Willis Towers Watson's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.7456. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Willis Towers Watson's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Willis Towers Watson's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.2 billion.
The EBITDA is a measure of a Willis Towers Watson's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $8.9 billion |
|---|---|
| Operating margin TTM | 18.92% |
| Gross profit TTM | $4 billion |
| Return on assets TTM | 2.96% |
| Return on equity TTM | 15.22% |
| Profit margin | 40.44% |
| Book value | $98.06 |
| Market capitalisation | $22.8 billion |
TTM: trailing 12 months
Dividend payout ratio: 25.47% of net profits
Recently Willis Towers Watson has paid out, on average, around 25.47% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.67% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Willis Towers Watson shareholders could enjoy a 1.67% return on their shares, in the form of dividend payments. In Willis Towers Watson's case, that would currently equate to about $3.24 per share.
While Willis Towers Watson's payout ratio might seem fairly standard, it's worth remembering that Willis Towers Watson may be investing much of the rest of its net profits in future growth.
Willis Towers Watson's most recent dividend payout was on 14 July 2022. The latest dividend was paid out to all shareholders who bought their shares by 28 June 2022 (the "ex-dividend date").
Willis Towers Watson's shares were split on a 3775:10000 basis on 4 January 2016. So if you had owned 10000 shares the day before before the split, the next day you'd have owned 3775 shares. This wouldn't directly have changed the overall worth of your Willis Towers Watson shares – just the quantity. However, indirectly, the new 164.9% higher share price could have impacted the market appetite for Willis Towers Watson shares which in turn could have impacted Willis Towers Watson's share price.
Over the last 12 months, Willis Towers Watson's shares have ranged in value from as little as $187.89 up to $248.0238. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Willis Towers Watson's is 0.7976. This would suggest that Willis Towers Watson's shares are less volatile than average (for this exchange).
Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. It operates through two segments, Health, Wealth and Career; and and Risk and Broking. The company offers actuarial support, plan design, and administrative services for traditional pension and retirement savings plans; plan management consulting, broking, and administration services for health and group benefit programs; and benefits outsourcing services. It also provides advice, data, software, and products to address clients' total rewards and talent issues. In addition, the company offers risk advice, insurance brokerage, and consulting services in the areas of property and casualty, aerospace, construction, and marine. Further, it offers investment consulting and discretionary management services to insurance and reinsurance companies; insurance consulting and technology, risk and capital management, pricing and predictive modeling, financial and regulatory reporting, financial and capital modeling, merger and acquisition, outsourcing, and business management services; wholesale insurance broking services to retail and wholesale brokers; and underwriting and capital management, capital market, and advisory and brokerage services. Additionally, the company provides primary medical and ancillary benefit exchange, and outsourcing services to active employees and retirees in the group and individual markets, as well as delivers healthcare and reimbursement accounts, including health savings accounts, health reimbursement arrangements, flexible spending accounts, and other consumer-directed accounts.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.